Market Tracker

09/02 12:42pm ET

EPIRUS Biopharmaceuticals Inc (NASDAQ:EPRS)

9.50
Data as of 12:22pm ET
 +0.1308 / +1.40%
Today’s Change
7.44
Today|||52-Week Range
82.80
-14.41%
Year-to-Date
No recent news for EPIRUS Biopharmaceuticals Inc.

Today’s Trading

Previous close9.37
Today’s open9.28
Day’s range9.10 - 9.50
Volume8,842
Average volume (3 months)54,516
Market cap$121.1M
Dividend yield--
Data as of 12:22pm ET, 09/02/2014

Growth & Valuation

Earnings growth (last year)+26.32%
Earnings growth (this year)+88.39%
Earnings growth (next 5 years)--
Revenue growth (last year)+17.38%
P/E ratio3.0
Price/Sales1.73
Price/Book1.72

Competitors

 Today’s
change
Today’s
% change
RLMDRelmada Therapeutics...0.000.00%
LPCNLipocine Inc-0.12-1.24%
MDGNMedgenics Inc-0.21-3.35%
EVARLombard Medical Inc-0.51-6.64%
Data as of 12:26pm ET, 09/02/2014

Financials

Last reporting dateSeptember 2, 2014
EPS forecast (this quarter)-$1.20
Annual revenue (last year)$14.7M
Annual profit (last year)-$38.6M
Net profit margin-262.15%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Amit D. Munshi
Chief Financial Officer &
Treasurer
Thomas A. Shea
Corporate headquarters
Boston, Massachusetts

Forecasts